RxDoctor Payments Data

Sarah Sarbacker, MD

Dermatology · Sioux Falls, SDNPI 1598762544

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.4% of the total across 444 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 25.8% of the total.

$7,580in general payments, 2019–2025

Across 444 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$957
  • Sun Pharmaceutical Industries Inc.$881
  • Lilly USA, LLC$613
  • Sanofi$528
  • Regeneron Healthcare Solutions, Inc.$379
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$7,00692%
  • Education$5748%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,580 in reported general payments places this provider in the 85th percentile of 44 dermatology providers in South Dakota.

See all dermatology providers in South Dakota

Medicare billing

Part B allowed, 2024
$335,781
Medicare patients
936
Services billed
3,057

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab12$40,939
Clobetasol Propionate37$2,090
Metronidazole20$931
ValacyclovirValacyclovir Hcl33$713
Triamcinolone Acetonide49$418
Ketoconazole13$178
Doxycycline Hyclate12$124
Minoxidil18$116
Terbinafine Hcl11$37

Paid to pharmacies, not to this prescriber.

Other dermatology in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →